Steve Abbott, a 10-year advanced prostate cancer survivor, is finally getting a life-extending treatment called Pluvicto, which has been in short supply in the U.S.
Dr. Brooke Edwards and Dr. Gary Kirsh talk about the therapy itself, as well as frustrations when these specialized drugs are in short supply.
